Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Acadia Pharmaceuticals buy Morgan Stanley

Start price
€16.27
12.07.24 / 50%
Target price
€25.68
12.07.25
Performance (%)
9.19%
End price
€17.77
13.07.25
Summary
This prediction ended on 13.07.25 with a price of €17.77. With a performance of 9.19%, the BUY prediction by Morgan_Stanley for Acadia Pharmaceuticals closed with a slight gain. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Acadia Pharmaceuticals -1.867% -1.867% 40.139%
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

Comments by Morgan_Stanley for this prediction

In the thread Acadia Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 9.19%
Target price 25.676
Change
Ends at 12.07.25

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Morgan Stanley from $30.00 to $28.00. They now have an "overweight" rating on the stock.
Ratings data for ACAD provided by MarketBeat

In the thread Trading Acadia Pharmaceuticals
Prediction Buy
Perf. (%) 9.19%
Target price 25.676
Change
Ends at 12.07.25

Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Morgan_Stanley for Acadia Pharmaceuticals

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€17.30
18.03.24
€27.59
18.03.25
-8.24%
19.03.25

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€27.40
19.12.23
€36.48
19.12.24
-41.15%
20.12.24